Juvenescence Ltd - 25 Apr 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, Executive Chairman of Juvenescence Ltd.
Issuer symbol
SER
Transactions as of
25 Apr 2023
Net transactions value
$0
Form type
4
Filing time
18 May 2023, 16:00:45 UTC
Previous filing
22 Mar 2023
Next filing
03 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Award $0 +756,429 $0.000000 756,429 25 Apr 2023 Common Stock 756,429 $0.6610 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under an Amended and Restated Secured Convertible Promissory Note between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.

Remarks:

Director by deputization